Alcon Inc(ALC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 27 at 4:35 AM ET (Korea 10/27 17:35)
Full metrics table
| Index | - | P/E | 53.67 | EPS (ttm) | 1.3 | Insider Own | 0.11% | Shs Outstand | 483.4M | Perf Week | 5.84% |
| Market Cap | 33.74B | Forward P/E | 17.74 | EPS next Y | 13.07% | Insider Trans | - | Shs Float | 481.6M | Perf Month | 8.56% |
| Enterprise Value | 37.59B | PEG | 1.34 | EPS next Q | 0.88 | Inst Own | 52.9% | Short Float | 3.71% | Perf Quarter | 1.27% |
| Income | 0.64B | P/S | 3.11 | EPS this Y | 13.67% | Inst Trans | 0.08% | Short Ratio | 10.01 | Perf Half Y | -7.92% |
| Sales | 10.86B | P/B | 1.57 | EPS next 5Y | 13.28% | ROA | 2.06% | Short Interest | 17.88M | Perf YTD | -11.19% |
| Book/sh | 44.67 | P/C | 23.17 | EPS past 3/5Y | 42.85% - | ROE | 2.94% | 52W High | -20.14% ($87.64) | Perf Year | -8% |
| Cash/sh | 3.02 | P/FCF | 19.39 | Sales past 3/5Y | 6.06% 8.77% | ROIC | 2.45% | 52W Low | 13.19% ($61.83) | Perf 3Y | 0.5% |
| Dividend Est. | $0.36 (0.52%) | EV/EBITDA | 15.25 | EPS Y/Y TTM | -39.47% | Gross Margin | 56.85% | Volatility(W/M) | 1.82% 1.66% | Perf 5Y | -15.78% |
| Dividend TTM | 0.36 | EV/Sales | 3.46 | Sales Y/Y TTM | 8.34% | Oper. Margin | 10.93% | ATR (14) | 1.33 | Perf 10Y | - |
| Dividend Ex-Date | 2026/5/6 | Quick Ratio | 1.3 | EPS Q/Q | -100% | Profit Margin | 5.92% | RSI (14) | 64.42 | Recom | 1.87 |
| Dividend Gr. 3/5Y | 15.62% 25.32% | Current Ratio | 2.09 | Sales Q/Q | 8.74% | SMA20 | 6.71% ($65.59) | Beta | 0.87 | Target Price | $83.48 |
| Payout | 16.97% | Debt/Eq | 0.25 | Earnings | 2026/8/10 | SMA50 | 3.12% ($67.87) | Rel Volume | 0.82 | Prev Close | $70.17 |
| Employees | 25942 | LT Debt/Eq | 0.22 | EPS/Sales Surpr. | 11.36% 0.72% | SMA200 | -2.98% ($72.14) | Avg Volume(3M) | 1.79M | Price | $69.99 |
| IPO | 2019/4/9 | Option/Short | Yes/Yes | Trades | 16922 | Volume | 1,463,509 | Change | -0.26% |
👁️ A leading global eye care company that supplies ophthalmic surgical equipment and supplies, contact lenses, and ophthalmic pharmaceuticals. Founded in 1945 in Texas, USA, it is currently headquartered in Geneva, Switzerland, and is a global leader in ophthalmic solutions that was spun off from Novartis in 2019 to return to standalone public listing.
Over the past 1 year, roughly in the middle
20% below its 1-year high.
Traded about as much as usual. That is 82% of its average volume.
ALC earns at a steady pace
Of every $100 in sales, $10.93 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +13.7% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $1,525. Peers typically go for $1,583.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -15.8%. The S&P 500 did +68% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.52% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 52.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #4 of 51 in the industry
Based on market cap of $34B.
Earnings Analysis · 8/10 Alcon ($ALC) Q2 2026 Earnings Analysis — Core EPS Beats Expectations, Full-Year Outlook Raised Investing Guides · 4/11 The Complete 2026 Guide to U.S. Dividend Aristocrats Investing Guides · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners See all posts on this stock FAQ
What kind of company is ALC?
ALC belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of ALC?
The market cap of ALC is approximately $33.7B, ranking 425 within its sector.
Does ALC pay dividends?
ALC has a dividend yield of approximately 0.52%, with an annual dividend of $0.36.
What is the P/E ratio of ALC?
ALC has a P/E ratio of approximately 53.7x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ALC?
ALC has recorded a 52-week high of $87.64 and a low of $61.83.
